2018 Emerging Clinical Chemistry and Immunodiagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers

January 2018 | 145 pages | ID: 2D6C926222BEN
Venture Planning Group

Abstracts

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.

The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 145 pages

Contents

CURRENT AND EMERGING TECHNOLOGIES

MONOCLONAL AND POLYCLONAL ANTIBODIES

IMMUNOASSAYS

a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

IT AND AUTOMATION

DRY CHEMISTRY

BIOSENSORS

ROBOTICS

MOLECULAR DIAGNOSTICS

a. Detection Technologies
  1. Radioactive Methods
  2. Non-Isotopic Methods
b. Instrumentation Review
  Abbott LCX
  BeckmanCoulter/Biomek FX
  Becton Dickinson
  Bio-Rad Gene Scope
  Gen-Probe
  Roche Cobas Amplicor
  Tecan LS Series
c. Biochips Genosensor, Microarrays, Labs-on-the-Chips Chemometrics

COMPETITIVE PROFILES

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE